Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 3/20 | 0.37 |
| ▸ | CKS1B | P61024 | 1/20 | 0.37 |
| ▸ | SKP1 | P63208 | 1/20 | 0.37 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | ACACA | Q13085 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8117400 | 1.00 | TDP1 (0.42) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL8346597 | 0.93 | EPHX1 (0.38) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL24517024 | 0.86 | EPHX1 (0.41) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL25961857 | 0.86 | EPHX1 (0.41) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL8123288 | 0.86 | EPHX1 (0.41) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL30605405 | 0.83 | EPHX1 (0.43) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL26966258 | 0.83 | EPHX1 (0.43) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL26966421 | 0.83 | EPHX1 (0.43) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL30605383 | 0.83 | EPHX1 (0.43) | TDP1EPHX1DRD2KMT2AMEN1 | |
| SCHEMBL24517021 | 0.83 | EPHX1 (0.43) | TDP1EPHX1DRD2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7060678-B2 | Peptides comprising furanoid sugar amino acids for the treatment of cancer | DABUR RESEARCH FOUNDATION (IN) | 2006-06-13 | — | — | US | disclosed |
| US-20050032707-A1 | Novel peptides comprising furanoid sugar amino acids for the treatment of cancer | DABUR RESEARCH FOUNDATION | 2005-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050032707-A1 | Novel peptides comprising furanoid sugar amino acids for the treatment of cancer | VIP, NGLY1, DNPEP | TDP1 3384/4885EPHX1 4074/4885DRD2 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.